company

RAYONEX BIOMEDICAL NORWAY AS

3660 RJUKAN

Return on Equity
72,73 %
Current Ratio
0,85
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue268 000
Net Income32 000
Total Assets103 000
Total Equity44 000
Income (NOK)2022
Revenue268 000
Expenditure230 000
Operating Profit39 000
Financial Income2 000
Financial Costs1 000
Financial Balance1 000
Earnings Before Tax40 000
Tax8 000
Net Income32 000
Balance (NOK)2022
Total Fixed Assets54 000
Total Current Assets50 000
Total Assets103 000
Total Retained Equity14 000
Total Equity44 000
Total Long-Term Debt0
Total Current Debt59 000
Total Equity and Debt103 000
Cash flow (NOK)2022
Sales Income268 000
Other Income0
Revenue268 000
Cost of Goods Sold178 000
Salary Costs0
Depreciation16 000
Impairment0
Expenditure230 000
Operating Profit39 000
Financial Income2 000
Financial Costs1 000
Financial Balance1 000
Dividends0
Net Income32 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures54 000
Total Tangible Assets54 000
Total Fiancial Fixed Assets0
Total Fixed Assets54 000
Stock0
Total Investments0
Cash, Bank41 000
Total Current Assets50 000
Total Assets103 000
Total Equity44 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors5 000
Unpaid Taxes19 000
Dividends0
Other Current Debt28 000
Total Current Debt59 000
Total Equity and Debt103 000
Financial indicators2022
Return on Equity72,73 %
Debt-to-Equity Ratio0
Operating Profit Margin14,55 %
Current Ratio0,85
Quick Ratio0,85
Equity Ratio0,43
Gross Profit Margin33,58 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English